OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Phase 2 Clinical Trial of KH617
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Status
- RECRUITING
- Phase
- NA
CUE-102 in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- NA
Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
- Status
- SUSPENDED
- Phase
- PHASE2
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
- Status
- RECRUITING
- Phase
- PHASE1